13F Data
13F filer · CIK 1507673

RP Management, LLC

New York, NY · filing since Q4 2018 · last filing Aug 6, 2025
Reported value
$0
$-138.8M vs prior
Positions
1
New / sold out
1 / 4
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $138.8M
Top-10 weight
–

Biggest buys vs Q1 2025

ChangeSecurityShares changeChange %Est. trade value
NewN/A0––

Biggest sells vs Q1 2025

ChangeSecurityShares changeChange %Est. trade value
Sold outBIOHAVEN LTD-2,936,507-100.0%$-70.6M
Sold outCYTOKINETICS, INC-980,392-100.0%$-39.4M
Sold outBIOCRYST PHARMACEUTICALS INC-3,846,154-100.0%$-28.8M
Sold outVIRACTA THERAPEUTICS INC-3,700-100.0%$-74

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2018: $146.1MQ1 2019: $199.9MQ2 2019: $163.0MQ3 2019: $156.1MQ4 2019: $442.3MQ1 2020: $322.1MQ2 2020: $517.4MQ3 2020: $667.3MQ4 2020: $326.0MQ1 2021: $266.4MQ2 2021: $205.1MQ3 2021: $214.3MQ4 2021: $225.4MQ1 2022: $245.9MQ2 2022: $253.2MQ3 2022: $216.4MQ4 2022: $84.9MQ1 2023: $72.2MQ2 2023: $97.3MQ3 2023: $103.6MQ4 2023: $148.7MQ1 2024: $180.1MQ2 2024: $178.8MQ3 2024: $227.7MQ4 2024: $227.7MQ1 2025: $138.8MQ2 2025: $0
Q4 2018Q2 2025

Holdings · Q2 2025

#SecuritySharesValueWeight
1N/AN/A0$0–